Big Move For NeuroMetrix, Inc.
Tue, Apr 14, 2020 at 05:30 PM
NeuroMetrix, Inc. (NURO:NASDAQ) rocketted at $3, representing a gain of 58.7%. On Mon 13 Apr 20, NURO:NASDAQ touched a New 2-Week High of $1.89. From Mon 30 Mar 20, the stock recorded 66.67% Up Days and 40.00% Green Days
The stock spiked on Tue 31 Dec 19 at $6.15 with a volume of 2M+.
About NeuroMetrix, Inc. (NURO:NASDAQ)
NeuroMetrix Inc manufactures and sells wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests that help patients and physicians manage chronic pain, nerve diseases, and sleep disorders.
Top 10 Gainers:
- Obalon Therapeutics, Inc. (OBLN:NASDAQ), 139.71%
- ReWalk Robotics Ltd. (RWLK:NASDAQ), 61.9%
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 61.74%
- NeuroMetrix, Inc. (NURO:NASDAQ), 58.73%
- MEI Pharma, Inc. (MEIP:NASDAQ), 49.7%
- Second Sight Medical Products, Inc. (EYES:NASDAQ), 47.06%
- MicroVision, Inc. (MVIS:NASDAQ), 44.68%
- Forestar Group Inc. (FOR:NYSE), 42.17%
- Immutep Limited (IMMP:NASDAQ), 40.77%
- RigNet, Inc. (RNET:NASDAQ), 38.79%